Drugmaker Leo Pharma Is Said to Pick Banks for Copenhagen IPO

Drugmaker Leo Pharma AS has lined up investment banks to lead a potential initial public offering as soon as this year in Copenhagen, according to people familiar with the matter.

The century-old drugmaker is working with Danske Bank AS, JPMorgan Chase & Co. and Morgan Stanley on the possible listing, said the people, who asked not to be named because the plans are private. It may hire additional banks to help arrange the stock sale, they added.

Leo Pharma, which specializes in skin conditions, was valued at about €3 billion ($3.5 billion) including debt when Nordic Capital acquired a ...